Diagnostic Electrocardiograph (ECG) is the process of recording the electrical activity of the heart over a period of time using electrodes placed on the skin. These electrodes detect the tiny electrical changes on the skin that arise from the heart muscle's electrophysiologic pattern of depolarizing and repolarizing during each heartbeat. It is a very commonly performed cardiology test.
The classification of diagnostic electrocardiograph (ECG) includes resting ECG, stress ECG, holter ECG, and the proportion of resting ECG in 2016 is about 65%, and the proportion is in decreasing trend from 2012 to 2016.
Diagnostic electrocardiograph (ECG) is widely used in hospitals, clinics and other field. The most proportion of diagnostic electrocardiograph (ECG) is hospitals, and the consumption proportion is about 72% in 2016.
Market competition is intense. GE Healthcare, Philips, BioTelemetry, Suzuken, Fukuda Denshi, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers: have been formed in the monopoly position in the industry.
According to this study, over the next five years the Diagnostic Electrocardiograph (ECG) market will register a 5.1% CAGR in terms of revenue, the global market size will reach US$ 6140 million by 2024, from US$ 4550 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diagnostic Electrocardiograph (ECG) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Electrocardiograph (ECG) market by product type, application, key manufacturers and key regions and countries.
This study considers the Diagnostic Electrocardiograph (ECG) value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
Resting ECG
Stress ECG
Holter ECG
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GE Healthcare
Philips
BioTelemetry
Suzuken
Fukuda Denshi
Welch Allyn
Mortara Instrument
NIHON KOHDEN
Spacelabs Healthcare
Mindray Medical
Schiller AG
Innomed
EDAN
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diagnostic Electrocardiograph (ECG) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Diagnostic Electrocardiograph (ECG) market by identifying its various subsegments.
Focuses on the key global Diagnostic Electrocardiograph (ECG) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diagnostic Electrocardiograph (ECG) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diagnostic Electrocardiograph (ECG) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
